Low-Level Laser Therapy for Treating Low Back Pain: 12-Month Follow-Up
*Corresponding Author: Travis M Sammons, Erchonia CorporationWarning: Undefined variable $university_str in /efsdata/omicsonline.org/httpdocs/includes/articles_utility.php on line 338
Warning: Undefined variable $university_str in /efsdata/omicsonline.org/httpdocs/includes/articles_utility.php on line 338
, Melbourne, FL, USA, Tel: 888-242-0571, Fax: 321.473.1608, Email: tsammons@erchonia.com
Received Date: Sep 30, 2019 / Accepted Date: Feb 07, 2020 / Published Date: Feb 14, 2020
Citation: Berry TS, Quarneri PJ, Roche G, Sammons TM (2020) Low-Lever Laser Therapy for Treating Low Back Pain: 12-Month Follow-Up. J Pain Relief 9: 347.
Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 2020 Berry TS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Low back pain is the leading cause of disability, with an estimated 632 million persons worldwide suffering and
producing societal costs exceeding $100 billion annually in the United States. The use of low-level lasers (LLLT) has
demonstrated beneficial effects for treating a range of painful musculoskeletal conditions, including low back pain. The
Food and Drug Administration granted LLLT the first 510(k) market clearance for the treatment of chronic low back
pain (K180197), based off a randomized, double-blind, sham-controlled study. The objective of the following study
was to reassess the safety and efficacy of LLLT in these same subjects 12 months after receiving LLLT for chronic
low back pain.